Article Listing - AstraZeneca and Bristol-Myers get first approval for diabetes drug Forxiga

STRATEGIES TO ACHIEVE CRITICAL MASS

20 April 1992

A successful alliance within the pharmaceutical industry is one in which both partners make money over a long period of...

NOVO NORDISK TO INVEST IN SPAIN

20 April 1992

The Danish drug manufacturer Novo Nordisk is looking for ways to invest in Spain through its Spanish subsidiary, Novo Nordisk...

SINGAPORE DENIES US TRADE CHARGES

20 April 1992

Singapore's Ministry of Trade and Industry has described as "misleading and inaccurate" charges of unfair trade practices which have been...

TWO NEW LICENSING DEALS FOR ROBERTS

20 April 1992

Roberts Pharmaceutical Corp of the USA has entered into two licensing agreements concerning prescription products, one in Germany and...

ROCHE AND XENOVA CD4 DRUG DEAL

20 April 1992

Swiss major Hoffmann-La Roche Ltd and its US subsidiary Hoffmann-La Roche Inc have entered into a license agreement with the...

FISONS TO COPROMOTE EPIPEN

20 April 1992

US technology-based health care concern Survival Technology Inc has announced that Center Laboratories, the licensee for the anti-allergy EpiPen auto-injector...

L'OREAL 1991 RESULTS

20 April 1992

Fench cosmetics company L'Oreal, majority shareholder of the French pharmaceutical concern Synthelabo, posted net profits for 1991 of just over...

CIBA-GEIGY INVESTMENT IN SINGAPORE

20 April 1992

Swiss chemical and pharmaceutical concern Ciba-Geigy is spending around S$12 million ($7.2 million) to expand its laboratories and warehousing facilities...

HAFSLUND NYCOMED'S CONTRAST AGENT

20 April 1992

Hafslund Nycomed is seeking approval in a number of countries to market a non-ionic X-ray contrast agent called Iodixanol. The...

ONO RESEARCHING NOVEL ANTIVIRAL

20 April 1992

Scientists at Ono Pharmaceutical and the Tokushima Bunri University in Japan have identified a potential antiviral agent from eucalyptus leaves,...

Showing 94261-94270 of 95376 articles